Status:

UNKNOWN

Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Major Depressive Disorder

Dysthymic Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary aim of this study is to test the feasibility and efficacy of Mindfulness Based Cognitive Therapy (MBCT) training for the treatment of depressive symptoms in patients with chronic pain. The...

Eligibility Criteria

Inclusion

  • The presence of Chronic Pain, which has persisted for at least 3 months.
  • Meets criteria of Major Depressive Disorder, Dysthymic Disorder or Depressive disorder NOS as defined by DSM-IV criteria.
  • Have a minimum score of depressive symptoms of \> 10 as rated on the QIDS-C, administered during the screen.
  • Able to provide written informed consent.
  • Adults 18 years or older
  • English-language literacy.

Exclusion

  • Serious suicide or homicide risk, as assessed by evaluating clinician.
  • Severe and unstable medical illness including cardiovascular, hepatic, renal, respiratory, endocrine, neurological or hematological disease for which hospitalization is likely to be required within the next half year.
  • The following DSM-IV disorders: any bipolar disorder (current or past), current psychotic symptoms, or a primary psychotic disorder (current or past). Entry of patients with anxiety disorder will be permitted if the depressive disorder is judged to be the predominant disorder, in order to increase accrual of a clinically relevant sample.
  • Active diagnosis of substance abuse or dependence disorders within the last 3 months.

Key Trial Info

Start Date :

November 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2014

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01473615

Start Date

November 1 2011

End Date

June 1 2014

Last Update

May 7 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MGH Depression Clinical and Research Program

Boston, Massachusetts, United States, 02114